These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31903121)

  • 1. Metastasis-on-a-chip mimicking the progression of kidney cancer in the liver for predicting treatment efficacy.
    Wang Y; Wu D; Wu G; Wu J; Lu S; Lo J; He Y; Zhao C; Zhao X; Zhang H; Wang S
    Theranostics; 2020; 10(1):300-311. PubMed ID: 31903121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a biomimetic liver tumor-on-a-chip model based on decellularized liver matrix for toxicity testing.
    Lu S; Cuzzucoli F; Jiang J; Liang LG; Wang Y; Kong M; Zhao X; Cui W; Li J; Wang S
    Lab Chip; 2018 Nov; 18(22):3379-3392. PubMed ID: 30298144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
    Bhattacharya S
    Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
    Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
    Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: Mechanism of 5-fluorouracil resistance in colorectal tumor cells.
    Hoshiba T; Tanaka M
    Biochim Biophys Acta; 2016 Nov; 1863(11):2749-2757. PubMed ID: 27558478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
    Leelakanok N; Geary SM; Salem AK
    J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterising a PDMS based 3D cell culturing microfluidic platform for screening chemotherapeutic drug cytotoxic activity.
    Khot MI; Levenstein MA; de Boer GN; Armstrong G; Maisey T; Svavarsdottir HS; Andrew H; Perry SL; Kapur N; Jayne DG
    Sci Rep; 2020 Sep; 10(1):15915. PubMed ID: 32985610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
    Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
    Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells.
    Emura T; Murakami Y; Nakagawa F; Fukushima M; Kitazato K
    Int J Mol Med; 2004 Apr; 13(4):545-9. PubMed ID: 15010854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N(3)-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU.
    Zhang X; Zhong JL; Liu W; Gao Z; Xue X; Yue P; Wang L; Zhao C; Xu W; Qu X
    Cancer Chemother Pharmacol; 2010 May; 66(1):11-9. PubMed ID: 19756602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLM-GelMA/tumor slice sandwich structured tumor on a chip for drug efficacy testing.
    Hu W; Bei HP; Jiang H; Wu D; Yu X; Zhou X; Sun Q; Lu Q; Du Q; Wang L; Luo Z; Wu G; Zhao X; Wang S
    Lab Chip; 2024 Jul; 24(15):3718-3727. PubMed ID: 38953554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs.
    Sung JH; Shuler ML
    Lab Chip; 2009 May; 9(10):1385-94. PubMed ID: 19417905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.
    Antunes J; Gaspar VM; Ferreira L; Monteiro M; Henrique R; Jerónimo C; Mano JF
    Acta Biomater; 2019 Aug; 94():392-409. PubMed ID: 31200118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic absorbable gelatin sponge loaded with 5-fluorouracil for treatment of tumors.
    Sun W; Chen Y; Yuan W
    Int J Nanomedicine; 2013; 8():1499-506. PubMed ID: 23626465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
    Tao L; Yang JK; Gu Y; Zhou X; Zhao AG; Zheng J; Zhu YJ
    World J Gastroenterol; 2015 Jan; 21(4):1125-39. PubMed ID: 25632185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
    Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
    J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of false-negative metastatic lymph nodes by a lymphatic drug delivery system with 5-fluorouracil.
    Fujii H; Horie S; Sukhbaatar A; Mishra R; Sakamoto M; Mori S; Kodama T
    Cancer Med; 2019 May; 8(5):2241-2251. PubMed ID: 30945479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.